Cellular Uptake of Chloroquine Is Dependent on Binding to Ferriprotoporphyrin IX and Is Independent of NHE Activity in Plasmodium falciparum by Bray, Patrick G. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/99/04/363/14 $2.00
The Journal of Cell Biology, Volume 145, Number 2, April 19, 1999 363Ð376
http://www.jcb.org 363
 
Cellular Uptake of Chloroquine Is Dependent on Binding to
Ferriprotoporphyrin IX and Is Independent of NHE Activity in
 
Plasmodium falciparum
 
Patrick G. Bray,* Omar Janneh,* Kaylene J. Raynes,* Mathirut Mungthin,* Hagai Ginsburg,
 
‡
 
 
and Stephen A. Ward*
 
*Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool L69 3BX, United Kingdom; and 
 
‡
 
Department of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel 
 
Abstract. 
 
Here we provide deﬁnitive evidence that 
chloroquine (CQ) uptake in 
 
Plasmodium falciparum
 
 
is determined by binding to ferriprotoporphyrin IX 
(FPIX). Speciﬁc proteinase inhibitors that block the 
degradation of hemoglobin and stop the generation of 
FPIX also inhibit CQ uptake. Food vacuole enzymes 
can generate cell-free binding, using human hemoglo-
bin as a substrate. This binding accounts for CQ uptake 
into intact cells and is subject to identical inhibitor 
speciﬁcity. Inhibition of CQ uptake by amiloride deriv-
atives occurs because of inhibition of CQ–FPIX bind-
ing rather than inhibition of the Na
 
1
 
/H
 
1
 
 exchanger 
(NHE). Inhibition of parasite NHE using a sodium-free 
medium does not inhibit CQ uptake nor does it alter 
the ability of amilorides to inhibit uptake. CQ resis-
 
tance is characterized by a reduced afﬁnity of CQ–FPIX 
binding that is reversible by verapamil. Diverse com-
pounds that are known to disrupt lysosomal pH can 
mimic the verapamil effect. These effects are seen in so-
dium-free medium and are not due to stimulation of the 
NHE. We propose that these compounds increase CQ 
accumulation and overcome CQ resistance by increas-
ing the pH of lysosomes and endosomes, thereby caus-
ing an increased afﬁnity of binding of CQ to FPIX.
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C
 
HLOROQUINE
 
 (CQ)
 
1
 
 has been one of the most suc-
cessful antimalarial agents ever developed. Unfor-
tunately, the emergence and spread of resistant
strains of 
 
Plasmodium falciparum
 
 has now rendered the
drug almost useless in most malaria endemic areas. The
immense clinical importance of 
 
falciparum
 
 malaria and
 
the universal success of CQ before the development of
resistance have provided the impetus for investigations
about the mode of action of CQ and the basis of resistance
at the cellular level. The activity of CQ depends on a high-
level accumulation within the malarial parasite and drug
resistance stems from reduced drug accumulation. Unfor-
tunately, a definitive mechanistic explanation for these ob-
servations has remained elusive (Fitch, 1970; Krogstad et
al., 1987; Ginsburg and Stein, 1991; Martiney et al., 1995;
Bray et al., 1998).
However, Wünsch and co-workers recently provided
compelling evidence for a novel mechanism of CQ resis-
tance based on the differential stimulation of the parasite
Na
 
1
 
/H
 
1
 
 exchanger (NHE; Wünsch et al., 1998). Previous
work from this group linked altered saturation kinetics
of initial CQ uptake to the CQ resistance phenotype
(Sanchez et al., 1997). They found that CQ uptake was in-
hibited competitively by specific inhibitors of NHE, pro-
viding evidence that the drug is actively transported
through the parasite NHE. They also showed that CQ
stimulates the NHE of chloroquine-sensitive (CQS) para-
sites and suggested that CQ is taken up by the NHE of
these parasites in the ensuing rapid burst of sodium–pro-
ton exchange (Wünsch et al., 1998). Conversely, it was
proposed that the NHE of chloroquine-resistant (CQR)
parasites did not transport CQ, since it was constitutively
activated and insensitive to further stimulation by CQ
(Wünsch et al., 1998). The reversal of CQ resistance by
verapamil was proposed to occur by modulating the activ-
ity of parasitic NHE via the calcium/calmodulin–depen-
dent pathway (Sanchez et al., 1997).
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Abbreviations used in this paper: 
 
AQ, amodiaquine; CQ, chloroquine;
CQR, chloroquine-resistant; CQS, chloroquine-sensitive; FPIX, ferripro-
toporphyrin IX; HB7, Hepes buffer at pH 7; NHE, Na
 
1
 
/H
 
1
 
 exchanger. 
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Since mammalian NHE is incapable of CQ transport
(Sanchez et al., 1997; Wünsch et al., 1998), this unusual
mechanism of drug uptake should be responsible for the
specificity of CQ for malarial parasites. Therefore, this
model is incompatible with the notion that the specificity
of CQ’s antimalarial action is caused by the formation of a
drug–ferriprotoporphyrin IX (FPIX) complex accumulat-
ing in the parasite upon exposure to CQ (Chou et al., 1980;
Fitch, 1983; Balsubramanian et al., 1984; Sullivan et al.,
1996; Ginsburg et al., 1998). In a process unique to the ma-
laria parasite, the FPIX released during proteolysis of he-
moglobin is polymerized into an inert crystalline substance
called hemozoin (Francis et al., 1997b). CQ inhibits this
polymerization process, causing a buildup of free FPIX
and/or CQ–FPIX complex that may ultimately kill the par-
asite (Slater, 1993; Dorn et al., 1995). Our own studies
suggest that the specificity, accumulation, and antimalarial
activity of CQ are all determined by the saturable equilib-
rium binding of CQ to FPIX (Bray et al., 1998).
We found that CQR parasites have a reduced apparent
affinity of CQ–FPIX binding compared with CQS para-
sites. We propose that the resistance mechanism acts spe-
cifically at the site of FPIX generation to alter the affinity
of CQ–FPIX binding rather than changing the active
transport of CQ across the parasite plasma membrane
(Bray et al., 1998). Here we provide definitive evidence
that CQ uptake is determined by the binding of CQ to
FPIX. In no part is the uptake of CQ controlled by the dif-
ferential stimulation of the NHE as proposed (Wünsch et
al., 1998). Furthermore, in CQR parasites reduced uptake
of CQ, reduced apparent affinity of CQ–FPIX binding,
and reversal of these parameters by verapamil are totally
independent of NHE activity. We also propose a mecha-
nistic basis for the reversal of CQ resistance in which resis-
tance reversers increase the pH of acid vesicles where
FPIX is generated. Therefore, this increases the affinity of
CQ–FPIX binding.
 
Materials and Methods
 
Reagents
 
Leupeptin and trans-epoxysuccinyl-leucylamido-(4-guanidino)-butane
(E64) were obtained from Boehringer Mannheim. Ro 40-4388, Ro 61-
7835, and Ro 61-9379 were provided by Dr. R.G. Ridley and Dr. R. Moon
of Hoffmann LaRoche. Triethylamine (TEA), diethylamine (DEA), dibu-
tylamine (DBA), 1-methyl-piperazine (1-MP) and dipropylamine (DPA)
were purchased from Aldrich Chemical Co. Silicon oil was purchased
from Dow Corning. 2
 
9
 
,7
 
9
 
-bis-(2-carboxyethyl)-5,6-carboxyfluorescein-ace-
toxymethylester (BCECF-AM) was purchased from Molecular Probes
Inc. [
 
3
 
H]CQ (50.4 Ci per mmol) was purchased from DuPont NEN.
[
 
3
 
H]Hypoxanthine was purchased from Amersham and [
 
3
 
H]amodiaquine
(AQ; 106 mCi per mmol) was synthesized in house. All other reagents
were purchased from Sigma Chemical Co.
 
Culture of P. falciparum and Drug Sensitivity Assays
 
Parasites were cultured and synchronized using standard techniques
(Trager and Jensen, 1976; Lambros and Vandenburg, 1979). Drug sensi-
tivity in the presence or absence of potential resistance reversers and he-
moglobinase inhibitors was determined according to the method of Des-
jardins et al. (1979). IC
 
50
 
 values were calculated for each assay using the
four parameter logistic method (Grafit program, Erithacus software; Kent
Laboratories). The effect of the combination of CQ and Ro 40-4388 on
parasite growth was tested by titration of the two drugs at fixed ratios pro-
 
portional to their IC
 
50
 
 values. The fractional inhibitory concentrations of
the resulting IC
 
50
 
 values were plotted as isobolograms (Berenbaum, 1978).
 
Measurement of the Effect of Proteinase Inhibitors
on Parasite Hemoglobin Digestion and Parasite
Hemozoin Content
 
Erythrocytes infected with the K1 strain were synchronized and cultivated
to the trophozoite stage and suspended in growth medium at a para-
sitemia of 10% and a hematocrit of 5%. At time 0, a sample was taken and
the infected cells were separated, counted, and analyzed for hemoglobin
and hemozoin as described below. The remaining cell suspension was in-
cubated for 3 h at 37
 
8
 
C in the absence or presence of 10 
 
m
 
M Ro 40-4388,
or 20 
 
m
 
M 
 
N-
 
acteyl-
 
L
 
-leucyl-
 
L
 
-leucyl-methional (ALLM), or 20 
 
m
 
M
 
N-
 
acetyl-
 
L
 
-leucyl-
 
L
 
-leucyl-norleucinal (ALLN), or 20 
 
m
 
M leupeptin. After
incubation, each was split into two aliquots. The infected cells from one al-
iquot were immediately separated from the uninfected cells using a Per-
coll–alanine gradient and counted as described (Ginsburg et al., 1998).
The hemoglobin and hemozoin concentrations of these cells were mea-
sured as described below. The infected cells from the remaining aliquot
were washed three times in prewarmed complete medium and returned to
culture for an additional 3-h incubation period. After incubation, the in-
fected cells were separated, counted, and the hemozoin concentration was
determined.
Hemoglobin concentration was measured using Drabkins reagent as
described (Ginsburg et al., 1998). The hemozoin concentration in the
pellet was determined after suspension in 2% (wt/vol) SDS in 0.1 M
NaHCO
 
3
 
, pH 9.1, followed by centrifugation at 14,000 rpm for 5 min. The
supernatant was discarded and this step repeated three times to remove all
nonhemozoin heme. The remaining hemozoin pellet was dissolved in 1 ml of
0.1 M NaOH and the absorbance was read at 400 nm using a Beckman
DU640 spectrophotometer. The amount of hemozoin/10
 
10
 
 cells was calcu-
lated from a calibration curve of known amounts of FPIX dissolved in 0.1 M
NaOH.
 
Measurement of the Uptake of 
 
[
 
3
 
H]
 
CQ by Intact 
Parasitized Erythrocytes
 
Infected erythrocytes were suspended in the appropriate buffer contain-
ing [
 
3
 
H]CQ, at a parasitemia of 1–2% and a hematocrit of 0.5%. At the re-
quired times, 100-
 
m
 
l samples were removed and the reaction was termi-
nated upon centrifugation of the cells (14,000 rpm for 2 min) through
silicon oil and processed for scintillation counting as described in Bray et al.
(1996). Parasite specific uptake was determined by subtracting counts be-
cause of an equal number of uninfected erythrocytes. Unless otherwise
stated, CQ accumulation is expressed as the cellular accumulation ratio
(CAR) which is the ratio of the amount of radiolabeled CQ in the para-
sites to the amount of radiolabeled CQ in a similar volume of buffer after
incubation.
The effect of the proteinase inhibitors Ro 40-4388, Ro 61-7835, Ro 61-
9379, ALLM, ALLN, leupeptin, and E64, on the steady-state uptake of
CQ was measured for 1 h at 37
 
8
 
C, in complete medium containing 1 nM
[
 
3
 
H]CQ. The reversibility of Ro 40-4388 (10 
 
m
 
M), ALLM (20 
 
m
 
M), and
ALLN (20 
 
m
 
M) was determined as follows: [
 
3
 
H]CQ was added at a con-
centration of 4 nM to inhibitor-treated and control groups. After 1 h, an
aliquot was taken and processed for scintillation counting as described
above. The remaining aliquot was washed three times in prewarmed me-
dium (37
 
8
 
C). [
 
3
 
H]CQ was re-introduced to the washed and control cells at
a concentration of 4 nM. After 1 h, samples were removed and processed
for counting. For the K1 isolate, parallel incubations were performed in
the presence of 10 
 
m
 
M verapamil. In the case of ALLM and ALLN, inhib-
itors were added 45 min before the initial addition of CQ and a 10-min
equilibration period was introduced after each wash.
CQ–FPIX binding parameters, in the absence or presence of 10 
 
m
 
M Ro
40-4388, were determined as described in Bray et al. (1998). For the K1
isolate, equilibrium binding parameters were obtained in sodium-free
buffer (122.5 mM choline chloride, 5 mM KCl, 1.2 mM CaCl
 
2
 
, 0.8 mM
MgCl
 
2
 
, 5.5 mM 
 
D
 
-glucose, 1.0 mM K
 
2
 
HPO
 
4
 
, 10 mM Hepes, pH 7.4) in the
absence or presence of 2 mM NH
 
4
 
Cl, 10 
 
m
 
M verapamil, or 100 nM mo-
nensin. Saturable uptake of CQ was calculated by subtracting nonsatura-
ble CQ uptake from the total CQ uptake as described previously (Bray et
al., 1998). Binding data are presented as Scatchard plots of saturable CQ
uptake. The apparent 
 
K
 
d
 
 of binding is given by the reciprocal of the slope
and the amount of bound drug is given by the x-intercept. 
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The effect of resistance modulators was determined over 1 h in growth
medium containing 1 nM [
 
3
 
H]CQ in the absence or presence of 10 
 
m
 
M
verapamil, 100 nM nigericin, 100 nM monensin, 2 mM NH
 
4
 
Cl, 2 mM
MTA, 2 mM TEA, 2 mM DEA, 2 mM DBA, 2 mM 1-MP, or 1 mM DPA.
Care was taken to ensure the medium pH was 7.4 throughout. Optimum
concentrations of these compounds were obtained in preliminary experi-
ments by measuring the effect of serial 1:3 log dilutions of drugs on CQ
uptake (data not shown).
To determine the effect of bicarbonate on the uptake of [
 
3
 
H]CQ,
growth medium containing various concentrations of bicarbonate was
shaken in atmospheric air at room temperature until the pH drift was
complete. The pH was adjusted to 7.4 with 1 M HCl. Parasites were incu-
bated in growth medium containing various concentrations of bicarbonate
and 3 nM [
 
3
 
H]CQ for 1 h and terminated thereafter.
 
Measurement of the Uptake of [
 
3
 
H]CQ Into
Isolated Parasites
 
Parasites were isolated from the host cell by selective lysis of the host cell
compartment (Elford, 1993). Ringer’s buffer modified to simulate an in-
tracellular milieu was used throughout (Wünsch et al., 1998). In selected
experiments, sodium chloride in the buffer system was replaced with mo-
lar equivalents of either choline chloride or
 
 N
 
-methyl-
 
D
 
-glucamine chlo-
ride. CQ uptake was determined by suspending the cell pellet containing
purified free parasites, in 200 
 
m
 
l of the appropriate buffer containing 50 nM
[
 
3
 
H]CQ, prewarmed to 37
 
8
 
C. Drug uptake was determined in the absence
or presence of 100 
 
m
 
M 5-
 
N
 
-ethyl-
 
N
 
-isopropyl amiloride (EIPA) or 10 
 
m
 
M
verapamil. At the appropriate time points, aliquots were removed and the
reaction was terminated by centrifugation (14,000 rpm, 1 min, at 4
 
8
 
C). The
sample was placed in an ice-bath, the supernatant was removed, and
the pellet was washed once in the appropriate ice-cold buffer without
[
 
3
 
H]CQ. After centrifugation (14,000 rpm, 1 min, at 4
 
8
 
C), the supernatant
was carefully removed with a drawn out glass Pasteur pipette and the
pellet was processed and counted for infected erythrocytes.
CQ uptake into isolated parasites was 
 
z
 
30% of intact infected erythro-
cytes’ uptake with over
 
 
 
30 min of CQ exposure. To investigate whether
this reduced CQ uptake occurs because of impaired NHE activity, we
compared the cytosolic pH of isolated parasites to that of parasites within
intact host erythrocytes. In agreement with previous reports (Wünsch et al.,
1998), we found no significant differences in cytosolic pH in these prepa-
rations. For example, the mean cytosolic pH for the K1 clone in its host
cell was 6.902 (SEM 
 
5 
 
0.045,
 
 n 
 
5 
 
12) compared with 6.992 (SEM 
 
5 
 
0.038,
 
n 
 
5 
 
22) when the parasite is liberated from the host cell. In addition, free
parasites exhibited a marked cytosolic acidification in sodium-free buffer
(0.76 pH unit 
 
6
 
 SEM 0.045,
 
 n 
 
5 
 
6), in full agreement with previous re-
ports (Bosia et al., 1993). Thus, NHE is functional in isolated parasites. 
We also investigated the possibility that the reduced CQ uptake occurs
because of a loss of viability. Isolated parasites were found to incorporate
radiolabeled hypoxanthine and isoleucine at the same rate as intact in-
fected erythrocytes for at least 6 h (data not shown). Since the parasites
are viable and NHE is functioning normally, we assumed that the reduced
accumulation of CQ happens because of cessation of hemoglobin traffick-
ing from the host cell at time 0 that reduces the amount of FPIX available
for CQ binding.
 
Determination of the Effect of Amiloride Analogues 
and Proteinase Inhibitors on FPIX Polymerization
 
Measurement of FPIX polymerization inhibition by amiloride analogues
and proteinase inhibitors employed a modification of the procedure de-
scribed by Raynes et al. (1996). An aliquot (100 
 
m
 
l) of trophozoite lysate
and FPIX (100 
 
m
 
l of 3 mM in 0.1 M NaOH) was mixed with an aliquot of
1 M HCl (10 
 
m
 
l) and sodium acetate (500 mM, pH 5.2) to give a volume of
900 
 
m
 
l in each tube. A series of drug concentrations was prepared in etha-
nol and 100 
 
m
 
l of each was added to the appropriate samples. The effect of
ethanol on the polymerization process was assessed by adding 100 
 
m
 
l of
ethanol to the control samples. Samples were mixed and incubated for 12 h,
with occasional mixing. After incubation, samples were centrifuged
(14,000 rpm, 15 min, at 21
 
8
 
C) and the hemozoin pellet repeatedly washed
with 2%(wt/vol) SDS in 0.1 M sodium bicarbonate, pH 9.0, with sonica-
tion (30 min, at 21
 
8
 
C; FS100 bath sonicator; Decon Ultrasonics Ltd.) until
the supernatant was clear (usually 3–4 times). After the final wash, the su-
pernatant was removed and the pellet was resuspended in 1 ml of 0.1 M
NaOH, incubated for an additional 1 h at room temperature. Afterwards,
samples were mixed with a pipette. The hemozoin content was determined
 
by measuring the absorbance at 400 nm (Beckmann DU640 spectropho-
tometer) using a 1-cm quartz cuvette. The amount of hemozoin formed
during incubation was corrected for preformed hemozoin (the amount of
preformed hemozoin in the parasite extract was determined from a sam-
ple containing extract, but no substrate, which was incubated and repeat-
edly washed with 2% SDS as previously stated). The concentration of
drug required to produce 50% inhibition of polymerization (IC
 
50
 
) was de-
termined graphically as described for the drug sensitivity assays.
 
Displacement of CQ Bound to FPIX-loaded Ghost 
Membranes and Parasite Debris
 
Erythrocyte ghost membranes were prepared as described previously
(Ginsburg et al., 1998). Membranes (0.27 mg protein) were loaded with
FPIX (2–5 
 
m
 
M) in 0.2 M Hepes buffer, pH 7.0 (HB7) at 37
 
8
 
C for 7 min fol-
lowed by centrifugation (14,000 rpm, 10 min). The supernatant was dis-
carded and the pellet was washed once in HB7. Samples of FPIX-loaded
membrane (0.01 mg protein) were suspended in 1 ml of HB7 containing
50 nM [
 
3
 
H]CQ and incubated in the absence or presence of various con-
centrations of the proteinase inhibitors, amiloride and the amiloride
analogues EIPA, 5-
 
N
 
-
 
N
 
-hexamethylene amiloride (HMA), and 5-
 
N
 
-isobu-
tyl-
 
N
 
-methyl amiloride (IBMA) for 10 min at 37
 
8
 
C. The membrane sus-
pension was centrifuged (14,000 rpm, 2 min), the supernatant removed,
and the pellet washed once in ice-cold HB7 without [
 
3
 
H]CQ. The remain-
ing pellet was solubilized and processed for counting, as described above.
To measure CQ–FPIX binding affinity in a parasite-free system, the
membranes were loaded in HB7 with 2 
 
m
 
M FPIX as above and samples
(0.01 mg protein) were incubated in 1 ml HB7 containing 3 nM [
 
3
 
H]CQ
and 5–10 
 
m
 
M nonradioactive CQ for 10 min at 37
 
8
 
C. The reaction was ter-
minated by centrifugation and samples were processed as above. Nonspe-
cific CQ binding was estimated from parallel incubation of FPIX-free
membranes and subtracted from the total binding for each CQ concentra-
tion. Binding affinity was estimated by a computer fit of the data to the
Michaelis-Menten equation. The displacement of preaccumulated [
 
3
 
H]CQ
from parasite debris by EIPA was measured as described previously (Bray
et al., 1998). Before lysis, erythrocytes infected with the CQS (HB3 strain)
were loaded with 50 nM [
 
3
 
H]CQ in complete medium for 30 min at 37
 
8
 
C.
 
Cell-free Assay for the Generation of CQ Binding Sites 
from Hemoglobin
 
Pure isolated food vacuoles were prepared by modifying the methods of
Goldberg et al. (1990) and Saliba et al. (1998). Suspensions of synchro-
nized trophozoites of the HB3 strain (
 
z
 
15% parasitemia) were washed
three times in PBS, pH 7.4. Each 5-ml sample of washed cell-pellet was
resuspended in PBS containing 0.15% saponin, incubated for 5 min, and
centrifuged (4,500 rpm for 5 min). The isolated trophozoites were washed
repeatedly in ice-cold PBS until the supernatant was clear. The trophozo-
ite pellet was collected and resuspended in 10 vol of ice-cold trituration
buffer (0.25 M sucrose, 10 mM sodium phosphate, 0.5% streptomycin sul-
fate, pH 7.1) and triturated three times on ice, using a 27-gauge 3/4 in nee-
dle. The suspension was centrifuged (13,000 rpm, 2 min, at 4
 
8
 
C), superna-
tant discarded, and the pellet resuspended in 5 vol of buffer (2 mM
magnesium sulfate, 100 mM potassium chloride, 10 mM sodium chloride,
25 mM Hepes, 25 mM sodium bicarbonate, 5 mM sodium phosphate, pH
7.1). To each 1 ml of the suspension 20 
 
m
 
l of 5 mg/ml DNaseI was added
and the suspension was incubated at 25
 
8
 
C for 5 min, followed by centrifu-
gation (13,000 rpm, 2 min, at 4
 
8
 
C). The supernatant was discarded and the
pellet was resuspended in 5 vol of ice-cold trituration buffer and triturated
once. The suspension was layered on top of 7 ml of ice-cold 42% Percoll
solution containing 0.25 M sucrose, 1.5 mM magnesium chloride, pH 7.1,
and centrifuged (12,000 rpm, 30 min, at 4
 
8
 
C). After centrifugation, the pu-
rified food vacuoles were harvested from the bottom of the gradient and
washed three times in ice-cold buffer (0.25 M sucrose, 10 mM sodium
phosphate, 1.5 mM magnesium chloride). Purity was checked by electron
microscopy and by using assays of host cell and parasite cytosol marker
enzymes as described previously (Saliba et al., 1998). Electron microscopy
revealed no contamination with other organelles or membranes and
 
z
 
50% of the vacuoles had intact membranes (data not shown). Contami-
nation with the parasite cytosolic enzyme lactate dehydrogenase was
 
,
 
0.7%. Compared with isolated trophozoites and contamination with
host cell acetylcholine esterase was below the limits of detection in the
assay. 
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Pellets of pure food vacuoles were added to 20 vol of ice-cold 500 mM
sodium acetate, pH 5, and immediately subjected to five cycles of rapid
freezing in liquid nitrogen and thawing at room temperature. The suspen-
sion was triturated 10 times with a 27-gauge needle and centrifuged
(13,000 rpm, 3 min, 4
 
8
 
C). The proteinase-rich supernatant was collected
and used for the cell-free assay. Protein content was measured using the
bicinchoninic acid assay (Smith et al., 1985). Samples of the enzyme extract
(2–10 
 
m
 
l) were added to 200 
 
m
 
l of 500 mM sodium acetate, pH 5, contain-
ing [
 
3
 
H]CQ or [
 
3
 
H]AQ. 100 
 
m
 
l of a 50-
 
m
 
M solution of human hemoglobin
was added to the mixture. Purified erythrocyte ghost membranes (0.01 mg
protein) were added to act as carriers for the CQ–FPIX complex. The sam-
ples were incubated for 1 h at 37
 
8
 
C in the absence or presence of 10 
 
m
 
M Ro
40-4388, or 20 
 
m
 
M Ro 61-7835, or 20 
 
m
 
M Ro 61-9379, or 20 mM leupeptin,
or 20 mM E64. After incubation, the samples were centrifuged (14,000 rpm,
1 min) and the supernatant was removed gently with a drawn out glass Pas-
teur pipette to avoid disturbing the pellet. The pellet was washed once in
ice-cold sodium acetate buffer without radiolabel and the remaining pellet
was solubilized and processed for counting as described above.
Measurement of Parasite Cytosolic pH
Parasite cytosolic pH was estimated using BCECF-AM as described by
Wünsch et al. (1998). The parasite suspension preloaded with BCECF was
incubated at 378C for 15 min in a perfusion chamber and the cells were al-
lowed to settle on a glass coverslip coated with poly-L-lysine. The experi-
mental chamber was transferred to the stage of an inverted Diaphot mi-
croscope (Nikon). At appropriate time points, 10 mM Ro 40-4388, or 2 mM
NH4Cl, or 2 mM methylamine was added to the perfusion buffer and the
pH was monitored. NHE activity in sodium-free buffer was monitored by
measuring the ability of the cell to recover from an acid load: the cells
were perfused with Ringer’s buffer containing 40 mM NH4Cl, after which
the perfusion buffer was changed to Ringer’s with one molar equivalent of
choline replacing sodium. When the fall in cytoplasmic pH stabilized, the
perfusion buffer was changed to sodium Ringer’s to allow the cytosolic pH
to recover.
Digital imaging microfluorimetry was carried out with an image analy-
sis system (Quanticell 700 series; Applied Imaging International Ltd.) in-
corporating an intensified camera (CCD; Photonic Science). Background
subtraction was performed independently for each excitation wavelength
used. The autofluorescence of unloaded parasites was negligible. The ex-
citation wavelengths used were 440 and 490 nm with emission measured
above 510 nm. Calibration was performed for each cell using the nigericin/
high K1 method that uses two or three buffers of known pH (Wünsch et
al., 1998). Since no ultrastructural detail could be observed under light mi-
croscopy, other than the food vacuole, the reported pH values are average
values for the entire parasite cytosol minus the food vacuole.
Results
Saturable CQ Uptake in P. falciparum Is Driven by 
Binding to FPIX
We determined the effect of a range of proteinase inhibi-
tors on CQ uptake. In addition to Ro 40-4388, two other
specific plasmepsin inhibitors, Ro 61-7835 and Ro 61-9379,
inhibited CQ uptake at low micromolar concentrations
(Fig. 1 A). Similar inhibition was observed with the tripep-
tide aldehydes, ALLM and ALLN, which are known in-
hibitors of the processing of proplasmepsins I and II into
active mature enzymes (Francis et al., 1997a). The other
cysteine proteinase inhibitors tested, E64 and leupeptin,
were much less effective. Inhibition of proplasmepsin pro-
cessing by the tripeptide aldehydes and the direct inhibi-
tion of the plasmepsins with Ro 40-4388 are reversible
(Francis et al., 1997a; Berry, C., personal communication).
We have established that the inhibition of CQ uptake by
both classes of compounds is also reversible, as predicted
by our hypothesis (Fig. 1, B and C). In CQS parasites, CQ
uptake is inhibited almost completely by the proteinase in-
hibitors (Fig. 1, A and B). In CQR parasites, the effect was
smaller but the inhibition of the resistance reversing effect
of verapamil was spectacular (Fig. 1 C). This observation
is in agreement with our hypothesis that verapamil in-
creases CQ uptake by increasing the affinity of CQ–FPIX
binding (Bray et al., 1998). Our data show that CQ–FPIX
binding determines the amount of drug that is taken up by
the parasite. The marked antagonism of CQ activity in the
presence of Ro 40-4388 (Fig. 1 D; Moon et al., 1997) sug-
gests that binding to FPIX also determines the antimalar-
ial activity of CQ.
Our model of the mechanism of CQ uptake is supported
by the demonstration that proteinase inhibitors efficiently
inhibit the degradation of hemoglobin and liberation of
FPIX under the same conditions used to inhibit CQ up-
take (Fig. 2). Hemoglobin digestion is almost completely
inhibited by ALLM, ALLN, and Ro 40-4388. On the other
hand, the effect of leupeptin was smaller. It is very difficult
to accurately measure the concentration of free FPIX in
parasites, so we have measured the concentration of he-
mozoin (polymerized FPIX). At the concentrations used,
none of the compounds had any direct effect on the poly-
merization of FPIX in vitro (data not shown). However,
all four compounds inhibited the production of hemozoin
by intact parasites to some extent (Fig. 2). These data
show that the concentration of FPIX is reduced when he-
moglobin digestion is blocked. The inhibition was much
more pronounced with ALLM, ALLN, and Ro 40-4388
than with leupeptin and was found to be reversible. Hemo-
zoin production resumed at the normal rate when the pro-
teinase inhibitors were removed by washing (Fig. 2). All
these results are in agreement with the effect of the same
inhibitors on CQ uptake (Fig. 1, A and B) and provide
compelling evidence that CQ uptake results from binding
of the drug to FPIX generated inside the infected erythro-
cyte.
The final piece of experimental evidence that proves the
central role of FPIX binding in the uptake of CQ was ob-
tained using a cell-free system. The binding characteristics
of intact CQS parasites can be reconstituted using an
erythrocyte ghost membrane preparation preloaded with
FPIX. The capacity (Bmax) of saturable CQ binding to
these membranes was dependent on the FPIX concentra-
tion, although at higher loading concentrations the appar-
ent binding affinity was reduced due to aggregation of
FPIX (data not shown). We measured an affinity (Kd) for
this interaction of 25 nM (Fig. 3 A). This value is the same
as the apparent Kd of saturable CQ uptake in CQS P. falci-
parum, again indicating that FPIX binding is all that is re-
quired to account for the saturable uptake of CQ (Bray et al.,
1998 and see below). Other experiments indicate that CQ
binding sites can be generated from native hemoglobin by
an extract from purified food vacuoles (Fig. 3 B). There is
little doubt that CQ binding is absent when either hemo-
globin or vacuole extract is omitted, or when the extract
has been heat-treated (data not shown). The same protein-
ase inhibitors that block the uptake of CQ into intact cells
block CQ binding in the cell-free system (Fig. 3 B). In fact,
the percent inhibition of CQ binding in the cell-free sys-
tem is almost perfectly correlated with the inhibition of
CQ uptake into intact cells by similar concentrations of
these compounds (R2 5 0.99, P , 0.001). AQ binding sites
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hibitor profile (Fig. 3 C). These data suggest that the
mechanism of AQ uptake is the same as that of CQ, i.e.,
the uptake of both drugs is driven by their binding to
FPIX.
The initial rate of uptake of CQ into CQS parasites is
rapid, prompting some authors to suggest that CQ is ac-
tively transported (Warhurst, 1986; Ferrari and Cutler,
1991; Sanchez et al., 1997). However, our data suggest that
the initial rate of CQ uptake is determined by the intrapar-
asitic binding of CQ to FPIX rather than active transport.
We found that after only a 5-min exposure of HB3 (CQS)
parasites to CQ, the number of CQ binding sites (Bmax)
was reduced from 17.2 mmol/liter to 6.9 mmol/liter by the
specific hemoglobinase inhibitor Ro 40-4388 (Fig. 4).
Figure 1. The effect of various proteinase inhibitors on the steady-state uptake (CAR) and activity of CQ. (A) The following inhibitors
are shown: E64 (closed square); leupeptin (open circle); Ro 61-9379 (closed triangle); Ro 61-7835 (open square); ALLN (closed in-
verted triangle); ALLM (open inverted triangle); and Ro 40-4388 (closed circle). (B) The reversible effect of proteinase inhibitors on
the steady-state accumulation of CQ by CQS (HB3) parasites. Control data without inhibitor are shown by light shaded bars. Dark
shaded bars show the effect before and after wash-off of 10 mM Ro 40-4388, 20 mM ALLM, and 20 mM ALLN. (C) The effect of the same
concentrations of proteinase inhibitors (pre-wash) on the steady-state accumulation of CQ by CQR (K1) parasites in the absence (light
shaded bars) or presence (dark shaded bars) of 10 mM verapamil. The effect of the inhibitors is reversible on washout (post-wash). Data
are means 6 SD from 10 experiments. (D) Antagonism of Ro 40-4388 and CQ against the CQS (HB3) parasite.The Journal of Cell Biology, Volume 145, 1999 368
The Uptake of CQ Is Independent of the Activity of
the NHE
In contrast to our explanation, others believe that CQ is
transported through the NHE of CQS parasites (Sanchez
et al., 1997; Wünsch et al., 1998). The NHE of CQR iso-
lates was activated constitutively, incapable of CQ trans-
port, and responsible for an elevated cytoplasmic pH
(Wünsch et al., 1998). We were not able to reproduce
these observations. In our hands, cytosolic pH is subject to
a greater degree of variation and is actually lower in the
resistant isolate (HB3, pH 7.183 6 SEM 0.04, n 5 17; K1,
pH 6.902 6 SEM 0.046, n 5 12). The reason for this dis-
crepancy is unknown but there may be a methodological
basis: our pH measurements are average values for the
whole cytosol (minus the food vacuole), whereas those of
Wünsch et al. (1998) refer to smaller regions of interest
within the cytosol. Elevated cytoplasmic pH of CQR iso-
lates is a fundamental tenet of the NHE hypothesis that
probably does not apply to the isolates used in this study.
Nonetheless, we have assessed the likely impact of small
variations in cytosolic pH on the binding of CQ to FPIX.
We found that the binding of CQ to FPIX in ghost mem-
branes is sensitive to buffer pH, but this effect is probably
not significant across the range of reported cytosolic pHs
(Fig. 5 A). We have also tested the effect of hemoglobin-
ase inhibition on cytosolic pH although such an effect
seems unlikely. We found that concentrations of Ro 40-
4388, sufficient to block CQ uptake, had no effect on cyto-
solic pH, indicating that blocking hemoglobin degradation
does not affect the cytosolic pH and that this compound
does not block CQ uptake by interacting with the parasite
NHE (Fig. 5 B).
It is proposed that CQ is driven through the NHE of
CQS parasites in a rapid burst of sodium-proton exchange
stimulated by CQ itself (Wünsch et al., 1998). We tested
this proposal directly by replacing the sodium ions in the
media with nonexchangeable cations and monitoring the
uptake of CQ into isolated parasites. This maneuver re-
sulted in a marked inhibition of the NHE of isolated para-
sites, as evidenced by the inability to recover from an acid
load (0.76 pH unit 6 SEM 0.045, n 5 6). It follows that so-
dium-free buffer should produce a very marked effect on
CQ uptake if the NHE is involved in this process. It was
observed that the initial rate of CQ uptake and steady-
state CQ accumulation into isolated CQS parasites (HB3
strain) remained constant regardless of the concentration
of sodium ions in the buffer (Fig. 6, A and B). These data
demonstrate that CQ uptake is independent of the para-
site’s NHE activity status. The reported ability of CQ to
stimulate the NHE of CQS parasites (Wünsch et al., 1998)
is interesting but it appears to have no involvement in the
mechanism of CQ uptake.
We also tested the effect of the sodium ion concentra-
tion on the uptake of CQ into isolated CQR parasites (K1
strain). The results, presented in Fig. 6 C, again show that
CQ uptake is unchanged when sodium ions are removed
from the buffer. In addition, the reversal of CQ resistance
by verapamil was independent of NHE activity, as it is re-
tained in sodium-free medium (Fig. 6 C). CQ accumula-
tion of CQR parasites is reduced by a similar ratio com-
pared with CQS parasites regardless of the sodium ion
concentration. Moreover, it is independent of the presence
or absence of the host cell (Fig. 6, A and C; Bray et al.,
1998). Therefore, all of the phenotypic features of CQ up-
take that distinguish CQR parasites from CQS parasites
are retained in sodium-free medium thereby providing
compelling evidence that the parasite NHE is not involved
in CQ resistance.
Amiloride Derivatives Bind to FPIX and Displace CQ
EIPA significantly inhibits the uptake of CQ even though
there are no sodium ions in the buffer and NHE is inactive
(Fig. 6, A and B). These results are interesting because
they indicate that EIPA inhibits CQ uptake by a mecha-
nism distinct from the inhibition of NHE. One possibility
is that EIPA inhibits the binding of CQ inside the parasite.
This assessment is supported by the data presented in Fig.
7, showing EIPA displacing prebound CQ from parasite
debris in a concentration-dependent manner. This interac-
tion is not due to displacement of CQ bound to the NHE
Figure 2. Proteinase inhibitors reversibly inhibit
the degradation of hemoglobin and the release of
FPIX in Plasmodium falciparum. Cell suspen-
sions were incubated for 3 h at 378C in the ab-
sence or presence of 10 mM Ro 40-4388, 20 mM
ALLM, 20 mM ALLN, or 20 mM leupeptin. Dark
shaded bars show concentration of hemoglobin.
Concentration of hemozoin is shown before in-
hibitor’s washout (light shaded bars) and after
washout with an additional 3-h incubation (un-
shaded bars). Percentage inhibition of hemoglo-
bin digestion and hemozoin production are given
above the bars. Data are means 6 SD from five
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Figure 3. CQ binding to FPIX in cell-free systems. (A) Binding of CQ to FPIX-
loaded ghost membranes. Membranes were preincubated with 2 mM FPIX,
washed, incubated with 50 nM [3H]CQ for 10 min at 378C and the amount of
bound CQ determined. Derived Kd 5 24.7 6 2.1 nM. Data are means 6 SD from
10 experiments. (B) CQ binding produced by enzymatic activity of a food vacuole
extract using human hemoglobin as a substrate. All inhibitors were used at 20 mM
except Ro 40-4388 that was used at 10 mM. Data are means 6 SEM from four
separate experiments. (C) AQ binding produced by enzymatic activity of a food
vacuole extract using human hemoglobin as a substrate. Inhibitor concentrations
are the same as for CQ. Data are means 6 SEM from four separate experiments.
protein as this could only account for z5% of the mea-
sured CQ binding (calculated from binding data given in
Sanchez et al., 1997).
Amiloride and its derivatives were shown to competi-
tively inhibit the saturable uptake of CQ (Wünsch et
al., 1998). Since we attribute saturable uptake of CQ to
CQ–FPIX binding, we have looked for an interaction of
these compounds with FPIX. Such an interaction is indi-
cated by the data in Fig. 8, showing amilorides inhibiting
FPIX polymerization. Indeed, HMA is almost as efficient
an inhibitor of FPIX polymerization as CQ itself. These
data suggest that amiloride derivatives might inhibit the
uptake of CQ into P. falciparum by preventing CQ–FPIX
binding. We tested this possibility directly and demon-
strated that these compounds inhibit CQ–FPIX binding in
loaded ghost membranes in a dose-dependent manner
(Fig. 9). Interestingly, the 50% inhibitory concentration
for EIPA was within the range reported for 50% inhibi-
tion of CQ uptake into P. falciparum by EIPA (Sanchez et
al., 1997). Furthermore, the rank order of inhibition of
CQ–FPIX binding by the amiloride analogues (HMA .
EIPA . IBMA @ amiloride) is the same as the rank order
of their inhibition of CQ uptake into intact parasitized
erythrocytes (Wünsch et al., 1998). These data indicate
that amiloride analogues do inhibit CQ uptake by block-
ing CQ–FPIX binding rather than inhibiting the parasite
NHE. We also hypothesized that verapamil reverses CQ
resistance by increasing the apparent affinity of CQ bind-
ing to FPIX (Bray et al., 1998). If our working model is
correct and if EIPA binds to FPIX at the expense of CQ,
then EIPA should ablate the verapamil effect; this is
clearly demonstrated in Fig. 6 C.
Lysosomotropic Compounds Selectively Increase the 
Apparent Affinity of CQ–FPIX Binding in
CQR Isolates
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(Fig. 6, A–C) it is still possible that CQ resistance may
arise from changes in the cytosolic pH (Martiney et al.,
1995). Accordingly, we examined the effect of various
agents known to perturb intracellular pH on the uptake of
CQ by CQS and CQR parasites. We found that ammo-
nium chloride, methylamine, a variety of alkylamines, and
the carboxylic ionophores, monensin and nigericin, selec-
tively increase the CQ accumulation of CQR parasites.
The maximum effect was found at concentrations of 1–2 mM
for amines and 100 nM for ionophores. In contrast, CQ ac-
cumulation by CQS parasites was either unaffected or re-
duced (Fig. 10 A). In this respect, the amines and iono-
phores mimic the effect of verapamil (Krogstad et al.,
1987). Ammonium chloride (Fig. 10 B) and methylamine
were also capable of reversing CQ resistance in the same
way as verapamil (although the effect was not as pro-
nounced). The remaining weak bases could not be as-
sessed for their resistance reversal potential because of
their inherent cytotoxicity.
Ammonium chloride, methylamine, and verapamil were
selected to investigate the possibility that resistance re-
versers alter cytosolic pH of CQR parasites. We found
that these compounds had no significant effect on cytoso-
lic pH at the low concentrations required to reverse re-
sistance (data not shown). Therefore, the ability of
these  compounds to increase CQ accumulation is unlikely
caused by any interaction with cytosolic pH regulators like
NHE. Indeed, any possible contribution of the NHE in the
process of resistance reversal is negated by the data show-
ing that ammonium chloride, monensin, and verapamil all
increase the apparent affinity of CQ binding to FPIX in
sodium-free medium, when the NHE is inactivated (Fig.
11, A–D).
We were also interested to see if any other cytosolic pH
regulators could influence CQ uptake. In common with
other eukaryotic cells, it is possible that P. falciparum par-
asites possess a chloride/bicarbonate exchange mechanism
(Bosia et al., 1993). If so, and if this protein can influence
CQ uptake as suggested (Martiney et al., 1995), then CQ
uptake should be influenced by the bicarbonate concen-
tration of the medium. It was found that CQ uptake into
CQS and CQR parasites was not effected by the concen-
tration of bicarbonate in the medium (Fig. 12). Taken to-
Figure 4. The initial uptake of CQ is determined by binding to
FPIX. Binding of CQ by CQS (HB3) parasites in the absence
(open circle) or presence (closed circle) of 10 mM Ro 40-4388. In
the absence of Ro 40-4388, the derived Kd 5 18.08 6 2.88 nM and
the derived capacity 5 17.2 6 2.82 mM. In the presence of Ro 40-
4388, the derived Kd 5 17.45 6 1.85 and the derived capacity 5
6.93 6 0.73 mM. Data points are means of duplicate observations
from three separate experiments.
Figure 5. (A) The effect of buffer pH on CQ–FPIX binding in a ghost membrane system. Membranes were preincubated with 5 mM FPIX,
washed, and incubated with 50 nM [3H]CQ for 10 min at 378C. Afterwards, the amount of bound CQ was determined. Data are means 6
SD from ten experiments. (B) The effect of Ro 40-4388 on the cytosolic pH of a single HB3 parasite. The proteinase inhibitor was
added and washed out at the time points shown. Other arrows indicate the start points of a two-point pH calibration. Shown is a single
representative trace from .20 similar experiments.Bray et al. Cellular Uptake of Chloroquine Is Dependent on Binding to FPIX 371
gether, our data suggest that none of the major cytosolic
pH regulators play a major role in the uptake of CQ or in
the mechanism of CQ resistance.
Discussion
The specificity of antimalarial activity of CQ stems from
the potential of malaria parasites to accumulate more CQ
than any other type of eukaryotic cell. CQR parasites of
some species, including P. falciparum, have evolved ways
to reduce the extent of CQ accumulation. A better under-
standing of the mechanism of CQ uptake in P. falciparum
would be a significant step forward since it should explain
the specificity of the drug and may also offer clues to the
basis of resistance. CQ undoubtedly penetrates the para-
site by passive diffusion as observed in other eukaryotic
cells (MacIntyre and Cutler, 1993). CQ is a diprotic weak
base and, as such, undoubtedly accumulates to some ex-
tent inside the acidic compartments of the parasite by a
proton trapping mechanism (Yayon et al., 1985). This
mechanism may account for a considerable concentration
of CQ inside cells (Geary et al., 1986). However, it proba-
bly does not account for the full extent of CQ accumula-
tion by P. falciparum, which is notably greater than CQ ac-
cumulation by other eukaryotic cells with large acidic
compartments (MacIntyre and Cutler, 1993). Pioneering
studies by Fitch in the 1970s demonstrated that CQ uptake
into  P. falciparum is saturable, energy-dependent, and
possibly inhibited by various compounds (Fitch, 1970;
Fitch et al., 1974). These studies suggest that malaria para-
sites possess an additional CQ concentrating mechanism
acting in concert with passive diffusion and proton trap-
ping. Two putative CQ concentrating mechanisms are cur-
rently under consideration: active CQ import (Warhurst,
1986) mediated by the parasite NHE (Sanchez et al., 1997;
Wünsch et al., 1998); and intracellular binding of CQ to
FPIX (Chou et al., 1980; Bray et al., 1998).
The NHE hypothesis initially appears plausible and
many of the supporting data are robust. However, a close
scrutiny of the available literature reveals some intriguing
inconsistencies that call into question the mechanistic ex-
planation offered by Wünsch et al. (1998). Particularly
problematic is the uptake of AQ, a close structural ana-
logue of CQ. Early studies showed that AQ competitively
inhibits the uptake of CQ in P. falciparum, suggesting that
the same mechanism drives the uptake of both drugs
Figure 6. The uptake of CQ into isolated parasites is not affected
by the buffer Na1 concentration. Cell suspensions were incu-
bated with 50 nM [3H]CQ at 378C and the amount of CQ taken
up was determined at the indicated time points. (A) Initial veloc-
ity of CQ uptake into isolated CQS (HB3) parasites in buffer
containing sodium (open circle), or choline (closed circle), or glu-
camine (open square), or choline plus 100 mM EIPA (closed tri-
angle). Data points are means of duplicate observations. (B)
Uptake of [3H]CQ into isolated CQS (HB3) parasites after 30
min at varying ratios of sodium ions to choline ions in the ab-
sence (light shading) and presence (dark shading) of 100 mM
EIPA. Data are means 6 SD from five experiments, each per-
formed in duplicate. (C) Uptake of [3H]CQ into isolated CQR
(K1) parasites after 30 min in the absence (light shading) and
presence (dark shading) of 10 mM verapamil in buffer containing
either sodium, choline, glucamine, or choline plus 100 mM EIPA.
Data are means 6 SD from five experiments, each performed in
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(Fitch et al., 1974). We reported that the uptake of AQ
into CQR parasites is equivalent to the uptake of CQ into
CQS parasites (Bray et al., 1996). It is hard to see how the
extensive uptake of AQ into CQR parasites can be driven
by an NHE that apparently is activated constitutively and
incapable of drug transport (Wünsch et al., 1998). 
A further difficulty is encountered when the effect of
verapamil is considered. Many studies have highlighted
the ability of verapamil to selectively increase the uptake
of CQ into CQR parasites (Krogstad et al., 1987; Wellems
et al., 1990; Bray et al., 1992; Walter et al., 1993; Bray et al.,
1996). Furthermore, this property of verapamil was linked
perfectly to CQ resistance in the progeny of a genetic cross
of CQR and CQS clones (Wellems et al., 1990). If NHE is
responsible for CQ uptake, then verapamil would some-
how have to selectively stimulate NHE of resistant para-
sites that is constitutively activated and incapable of CQ
transport. However, this is an unlikely scenario, doubly so,
when one considers the large quantity of literature demon-
strating verapamil functioning to inhibit rather than stimu-
late drug transporters and ion channels (Gottesman and
Pastan, 1993; Bray and Ward, 1998). The active transport
model is inconsistent with our own data showing a role for
CQ–FPIX binding in the uptake of CQ, in verapamil-sen-
sitive CQ resistance and in the uptake of AQ (Bray et al.,
1998). We rigorously tested these two hypotheses and
found that the FPIX binding model remains valid, whereas
the altered NHE model failed.
We have tested the assertion that a rapid burst of so-
dium–proton exchange is required to drive uptake of CQ
into CQS parasites. We used isolated parasites for these
experiments and assumed that NHE activity is not im-
paired under such conditions. We show here as others
have shown that parasitic NHE is fully functional after the
parasite has been isolated from its host cell (Bosia et
al., 1993). We found that replacing sodium ions in the
buffer with nonexchangeable cations, such as choline or
N-methyl-D-glucamine, inactivated NHE but had no effect
on the amount of CQ taken up at steady-state by isolated
Figure 7. EIPA-dependent displacement of prebound CQ from
cell debris from cells preloaded with [3H]CQ. Cell debris were
exposed to EIPA (closed circle) at the concentrations indicated.
Data are means 6 SD from five experiments.
Figure 8. Inhibition of FPIX polymerization by CQ and
amiloride analogues. Data are presented for CQ (open circle),
HMA (closed inverted triangle), EIPA (closed triangle), and
amiloride (closed circle). Data are means 6 SD from three ex-
periments.
Figure 9. Displacement of CQ bound to FPIX-loaded ghost
membranes. Membranes were preincubated with 5 mM FPIX,
washed, incubated with 50 nM [3H]CQ for 10 min at 378C, and
the amount of bound CQ determined. Data are presented for
HMA (closed inverted triangle), EIPA (closed triangle), IBMA
(closed square), and amiloride (closed circle). Data are means 6
SD from 10 experiments.Bray et al. Cellular Uptake of Chloroquine Is Dependent on Binding to FPIX 373
CQS parasites (Fig. 6 B). Moreover, sodium-free buffer
had no effect on the initial velocity of CQ uptake into
CQS parasites (Fig. 6 A). This was measured over the first
5 min after the addition of CQ, which coincides with the
reported period of maximal stimulated NHE activity
(Wünsch et al., 1998). Since there can be no rapid burst of
sodium–proton exchange in sodium-free buffer and CQ
uptake is not altered by these conditions, our results
strongly suggest that any ability of CQ to stimulate the
NHE of CQS parasites (Wünsch et al., 1998) is unrelated
to the mechanism of CQ uptake. In addition, we found
that stimulation of CQ uptake into CQR parasites, pro-
duced by verapamil and other resistance reversers, was un-
related to the activity of the NHE because these effects
are retained in sodium-free buffer (Figs. 6 C and 11, A–D).
Consequently, the effect of verapamil on the uptake of CQ
cannot be attributed to modulation of NHE activity via
the calcium-calmodulin regulatory pathway, as postulated
by Sanchez et al. (1997). Hence, the clone-specific pheno-
typic characteristics of CQ uptake into CQS and CQR
parasites are retained in conditions which completely inac-
tivate the NHE (Figs. 6, A–C, and 11, A–D). Therefore, it
is difficult to see how these characteristics can be related
in any way to the activity of the parasite NHE.
We have demonstrated that amiloride analogue in-
hibition of CQ uptake occurs because of inhibition of
CQ–FPIX binding by these compounds, rather than the
inhibition of the parasite NHE. In a critical series of exper-
iments, we were able to demonstrate that the inhibition of
CQ uptake by EIPA was distinct from any activity of this
drug against NHE. CQ uptake is undiminished in sodium–
free buffer when NHE is inactive, yet it is effectively inhib-
ited when EIPA is present in this buffer (Fig. 6, A–C).
These data strongly suggest that blocking CQ uptake by
EIPA is caused by inhibition of a process that does not re-
quire sodium–proton exchange for CQ uptake. This di-
rectly violates the fundamental requirement of the NHE
hypothesis. 
There is solid experimental support for the FPIX model
(Balsubramian et al., 1984; Sullivan et al., 1996; Bray et al.,
1998). Therefore, the demonstration that EIPA displaces
prebound CQ from parasite debris (Fig. 7), binds to
FPIX (Fig. 8), and inhibits the binding of CQ to FPIX-
loaded ghost membranes (Fig. 9) provides direct evidence
that EIPA inhibits CQ uptake into parasites by binding
to FPIX. Furthermore, the rank order of activity of
the  amiloride analogues (HMA . EIPA . IBMA @
amiloride) is the same for the inhibition of CQ–FPIX
binding (Figs. 8 and 9) as it is for the inhibition of CQ up-
take (Wünsch et al., 1998). Examination of the chemical
structure of amiloride reveals that either of the two termi-
nal amino groups of the guanidine function has the poten-
Figure 10. Clone-specific effects of resistance modulators on the uptake
and activity of CQ in CQS and CQR P. falciparum. (A) CQ uptake data
are presented for CQS (HB3) parasites (light shading) and CQR (K1)
parasites (dark shading). Data are means 6 SD from five experiments.
(B) CQ activity data are presented for CQS (3D7) parasites in the ab-
sence (open circle) and presence (closed circle) of ammonium chloride
and for CQR (K1) parasites in the absence (open square) and presence
(closed square) of ammonium chloride and in the presence of verapamil
(closed triangle). Data are means from three sensitivity assays, each
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tial to coordinate with the iron center of the porphyrin as
an axial ligand (Rocha Gonslaves et al., 1991). Hoe 370, a
specific NHE inhibitor that is structurally unrelated to the
amiloride analogues, also has been shown to inhibit CQ
uptake (Wünsch et al., 1998). Note, this compound also
contains a guanidine function and may also bind to FPIX.
Inhibition of CQ uptake by these specific NHE inhibitors
provided the best evidence of active import of CQ through
the NHE. However, in the light of the data reported here,
we believe that this property of NHE inhibitors must now
be considered to support the alternative theory that CQ
uptake is governed by its binding to FPIX.
The central theme of the studies presented here is the
definitive proof, after some thirty years of controversy,
that saturable CQ uptake is driven by its binding to FPIX.
We recently demonstrated that Ro 40-4388, a potent and
specific inhibitor of the parasite proteolytic enzyme plas-
mepsin I (Moon et al., 1997), produces a concentration-
dependent reduction in the number of CQ binding sites of
intact parasitized erythrocytes (Bray et al., 1998). Here we
have extended this observation blocking hemoglobin deg-
radation by two distinct mechanisms. The plasmepsins are
thought to initiate hemoglobin degradation by cutting the
Phe33-Leu34 bond of the alpha chain. This unfolds the he-
moglobin tetramer, allowing further proteolysis and the
release of FPIX (Goldberg et al., 1991; Gluzman et al.,
Figure 11. Resistance modu-
lators increase the apparent
affinity of CQ binding to
CQR parasites regardless of
NHE activity. (A) The effect
of substituting choline for so-
dium on the cytosolic pH of a
single K1 (CQR) parasite in
its host cell. Cells were pre-
loaded with 40 mM ammo-
nium chloride in sodium
buffer. The arrows indicate
subsequent perfusion with
choline buffer followed by
sodium buffer perfusion
when acidification was com-
plete. Shown is a single rep-
resentative trace from 12
similar experiments. (B) CQ
binding in choline buffer, in
the absence (open circle) or
presence (closed circle) of
verapamil. (C) CQ bind-
ing in the absence (open cir-
cle) or presence (closed square) of monensin. (D) CQ binding in the absence (open circle) or presence (closed triangle) of ammo-
nium chloride. Data points are means from three experiments.Bray et al. Cellular Uptake of Chloroquine Is Dependent on Binding to FPIX 375
1994; Francis et al., 1997b). Although the parasite contains
other hemoglobinase enzymes, there is good evidence that
the inhibition of plasmepsin I alone is sufficient to stop the
digestion of hemoglobin and release of FPIX (Francis et al.,
1994, 1997b). We have used Ro 40-4388, Ro 61-7835, and
Ro 61-9379 to block hemoglobin cleavage. All three com-
pounds are potent inhibitors of the parasite aspartic he-
moglobinase enzymes, plasmepsin I and plasmepsin II
(Moon et al., 1997; Bray et al., 1998; Moon, R.P., personal
communication). In addition we have prevented proplas-
mepsin processing with ALLM and ALLN. We provide
evidence that the reversible inhibition of CQ binding pro-
duced by Ro 40-4388 and other proteinase inhibitors stems
from a reversible cessation of hemoglobin digestion and
FPIX release in the parasite (Figs. 1, A–C, and 2).
Perhaps the most convincing support for our hypothesis
comes from the demonstration that a purified food vacu-
ole extract can generate CQ binding sites in a cell-free sys-
tem using human hemoglobin as a substrate (Fig. 3 B).
The correlation of the inhibitor specificity of this process
with that of CQ uptake into intact cells is compelling. Nev-
ertheless, it is important that any proposed mechanism ac-
counts quantitatively as well as qualitatively for CQ up-
take. Further analysis of the data presented in Fig. 3 B
reveals that this is the case. The extract from 106 vacuoles
generates 123.72 fmol of CQ binding sites. At the external
CQ concentration used (0.61 nM) this equates to a CAR
of 2,399 (assuming one food vacuole per infected erythro-
cyte). This figure compares with a CAR of z2,600 for in-
tact parasites under similar conditions (Fig. 1 A). Much
proteolytic activity has undoubtedly been lost in our assay
because of poor enzyme extraction efficiency and leakage
of enzymes from vacuoles during purification. Therefore,
intact parasites clearly possess more than enough pro-
teolytic activity to account for the uptake of CQ.
FPIX–CQ binding is the principal driving force for drug
uptake including the initial CQ uptake kinetics, measured
after 5 min exposure to CQ and previously attributed to a
carrier-mediated import mechanism (Fig. 4). Published es-
timates of the rate of hemoglobin digestion adequately de-
fend this argument. It is estimated that each parasite de-
grades 0.06 fmol of hemoglobin per hour (Goldberg et al.,
1990). This would liberate 50 mmol FPIX per liter of para-
sites in 5 min, i.e., more than enough to account for initial
rate of bound CQ (17.2 mmol per liter in 5 min, Fig. 4)
even at a stoichiometry of 2 FPIX:1 CQ. If so, this indi-
cates that CQ uptake may limit itself by stopping hemo-
globin digestion since the steady-state Bmax is only 30–40
mmol per liter (Bray et al., 1998). CQ uptake might be lim-
ited by CQ–FPIX inhibition of the hemoglobinase en-
zymes. It is possible that sufficient CQ–FPIX complex
remains within the vacuole to inhibit the proteolytic
enzymes (Vander Jagt et al., 1987; Gluzman et al., 1994).
To quote Chou et al. (1980), “Unequivocal identifica-
tion of an isolated substance as a drug receptor requires
(a) that affinities and specificities of binding of the drug
match those of the receptor, (b) that the drug is ineffective
when the putative receptor is absent from the organism,
and (c) that drug effectiveness returns when the receptor
is reintroduced into the organism.” The specificity of he-
moglobinase inhibitors that inhibit cellular CQ uptake is
identical to their specificity in the cell-free enzymatic CQ
binding assay (Figs. 1 A and 3 B). These drugs are specific
and reversible inhibitors of FPIX generation (Fig. 2). This
biochemical knockout has permitted us to show that FPIX
can be reversibly removed, causing a reversible inhibition
of drug uptake (Figs. 1 B and 2). In addition to governing
the uptake of the drug, CQ–FPIX binding determines anti-
malarial activity since the combination of CQ and hemo-
globinase inhibitors is markedly antagonistic (Fig. 3 C;
Moon et al., 1997). Furthermore, we were able to match
the affinity of binding of CQ to CQS parasites to the affin-
ity of CQ–FPIX binding in a parasite-free system (Fig. 3
A). Thus, all of the above criteria have been satisfied and
identify FPIX as the CQ receptor in P. falciparum.
Our data indicate that NHE has no involvement in the
mechanism of CQ resistance (Figs. 6 and 11). Indeed, any
involvement of cytosolic pH regulation seems unlikely. In-
stead, our data suggest that CQ resistance stems from an
alteration in the local environment of FPIX generation in
acid vesicles. We found that a wide range of lysosomotro-
pic compounds mimics the effects of verapamil (Fig. 10
A). This could indicate the inhibition of a drug transporter
similar to P-glycoprotein. However, since many of these
compounds are not known to interact with P-glycoprotein,
we suggest an alternative mode of resistance reversal. The
concentrations required to reverse resistance produced no
alkalinization of the parasite cytosol but might be ex-
pected to produce a significant alkalinization of lysosomes
and endosomes (Millot et al., 1998). There is evidence in
the literature that hemoglobin digestion begins in hemo-
globin delivery vesicles, before they fuse with the food
vacuole (Slomianny and Prensier, 1990). To protect the
parasite, the resistance mechanism must be operational
throughout the endocytic pathway. The intracellular local-
ization of CQ resistance gene CG2 throughout the en-
docytic pathway is certainly consistent with this hypothesis
(Su et al., 1997). It is our belief that CQ resistance results
from a selective change in vesicular function within rel-
Figure 12. Clone-specific CQ uptake characteristics are indepen-
dent of the concentration of bicarbonate in the medium. Data are
presented for the CQR (K1) clone (closed circle) and the CQS
(HB3) clone (open circle). Data are means 6 SD from five ex-
periments.The Journal of Cell Biology, Volume 145, 1999 376
evant hemoglobin processing acidic compartments. This
reduces the affinity of CQ–FPIX binding that can be
reversed by lysosomotropic agents. CG2 and related pro-
teins could potentially alter the binding of CQ to FPIX by
directly binding to FPIX or by altering vesicular pH or
buffering capacity. All of these mechanisms could be mod-
ulated by vesicle alkalinization and are currently under in-
vestigation in our laboratory.
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